QUANTRO Therapeutics is a visionary and dynamic start-up company that strives to discover and develop novel effective therapeutics that interfere with disease-causing transcriptional programs in cancer and other diseases. Based on cutting edge technologies in the areas of applied molecular biology, functional-genetics and transcriptomics QUANTRO Therapeutics will assemble a highly innovative drug discovery pipeline that employs time-resolved RNA sequencing and comparative transcriptomics to identify and develop drug candidates interfering with transcriptional regulators.
QUANTRO Therapeutics was founded as a spin-off of the Institute of Molecular Biotechnology (IMBA) and the Research Institute of Molecular Pathology (IMP). Our R&D labs and company headquarter are located in the Startup Labs of the Vienna Business Agency in VBC6 on campus. We are a diverse and dynamic team working with an international background and in collaboration with outstanding and globally recognized scientific experts to transform therapeutic approaches in oncology.
Get in touch with us, and for more information see www.quantro-tx.com